- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- January 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 120 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2025
- 250 Pages
Global
From €4478EUR$4,999USD£3,817GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- October 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 153 Pages
Global
From €3807EUR$4,250USD£3,245GBP
- Report
- February 2025
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- January 2025
- 52 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- February 2025
Global, Europe, United States, ... Global, Europe, United States, Japan
From €3359EUR$3,750USD£2,863GBP
- Report
- February 2025
Latin America
From €8509EUR$9,500USD£7,254GBP
- Report
- August 2024
Europe, United States, ... Europe, United States, Japan
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2024
Europe, United States, ... Europe, United States, Japan
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2024
Europe, United States, ... Europe, United States, Japan
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €4031EUR$4,500USD£3,436GBP
- Report
- February 2025
Middle East
From €4031EUR$4,500USD£3,436GBP
- Report
- February 2025
Canada, Mexico, North America Canada, Mexico, North America
From €2194EUR$2,450USD£1,871GBP
- Report
- February 2025
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €2553EUR$2,850USD£2,176GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more